Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Update

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 105,600 shares, a growth of 181.6% from the November 30th total of 37,500 shares. Based on an average trading volume of 133,500 shares, the days-to-cover ratio is currently 0.8 days.

Tevogen Bio Trading Up 10.3 %

NASDAQ:TVGNW traded up $0.01 during trading hours on Friday, reaching $0.06. 105,149 shares of the company’s stock were exchanged, compared to its average volume of 66,462. Tevogen Bio has a 12 month low of $0.01 and a 12 month high of $0.28. The business’s 50-day simple moving average is $0.06 and its two-hundred day simple moving average is $0.04.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.